Developmental funds provide an essential base of support for the strategic initiatives of the Cancer Center consistent with its overall planning processes. During the current project period this support was applied in three areas: recruitment of new faculty, support of pilot projects and development of shared resources. A total of fifteen new faculty were provided with recruitment support and a significant number of these have subsequently obtained peer-reviewed funding. A total of ten pilot projects were funded over the project period with a significant publication and subsequent funding record. And finally, developmental funds supported three new shared resources which are now being presented as established facilities in this application. Without question, developmental funds have provided an excellent return on investment in all three categories of support. Given the continued growth in the Cancer Center's overall research enterprise and the successful use of developmental funds in the current project period, a new request of $525,000 per year is felt to be justified. This would be allocated as $250,000 per year for new faculty recruitment, $100,000 per year for funding of pilot projects, and $175,000 per year for development of shared resources. The new shared resource facilities that will be developed with the help of these funds include the Viral Vector Core, the Epigenomics Core, and the Cancer Therapeutics and Diagnostic Screening Facility. All three cores will address important needs of the Cancer Center and will complement the function and services of already existing cores.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA060553-18S3
Application #
8486509
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2013-07-31
Budget Start
2012-09-06
Budget End
2013-07-31
Support Year
18
Fiscal Year
2012
Total Cost
$500,019
Indirect Cost
$85,187
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Moinpour, Carol M; Donaldson, Gary W; Davis, Kimberly M et al. (2017) The challenge of measuring intra-individual change in fatigue during cancer treatment. Qual Life Res 26:259-271
Lamar, Tyra; Vanoye, Carlos G; Calhoun, Jeffrey et al. (2017) SCN3A deficiency associated with increased seizure susceptibility. Neurobiol Dis 102:38-48
Yu, Dou; Khan, Omar F; SuvĂ , Mario L et al. (2017) Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression. Proc Natl Acad Sci U S A 114:E6147-E6156
Mohr, David C; Tomasino, Kathryn Noth; Lattie, Emily G et al. (2017) IntelliCare: An Eclectic, Skills-Based App Suite for the Treatment of Depression and Anxiety. J Med Internet Res 19:e10
Apple, Alexandra C; Ryals, Anthony J; Alpert, Kathryn I et al. (2017) Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns. Neuroimage Clin 14:685-691
Lampe, Johanna W; Huang, Ying; Neuhouser, Marian L et al. (2017) Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort. Am J Clin Nutr 105:466-475
Ichikawa, Yuichi; Connelly, Caitlin F; Appleboim, Alon et al. (2017) A synthetic biology approach to probing nucleosome symmetry. Elife 6:
Zhou, Qiyuan; Dai, Jingbo; Chen, Tianji et al. (2017) Downregulation of PKC?/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion. Cell Signal 38:49-59
Park, Jong Kook; Peng, Han; Yang, Wending et al. (2017) miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways. FASEB J 31:256-265
Raji, Idris; Yadudu, Fatima; Janeira, Emily et al. (2017) Bifunctional conjugates with potent inhibitory activity towards cyclooxygenase and histone deacetylase. Bioorg Med Chem 25:1202-1218

Showing the most recent 10 out of 1878 publications